Black Diamond Therapeutics, Inc. Common Stock BDTX
$2.02
-3.81%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $10.25
- Implied Upside
- +407.4%
- Price Target Range
- $8.00 – $14.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-29 | BTIGRobert Burns |
Maintains | Buy | $10 → $11 |
| 2026-03-17 | WedbushRobert Driscoll |
Maintains | Outperform | $13 → $14 |
| 2026-01-16 | Piper SandlerKelsey Goodwin |
Maintains | Overweight | $9 → $8 |
| 2025-12-04 | GuggenheimBrad Canino |
Downgrades | Buy → Neutral | — |
| 2025-11-18 | Piper SandlerKelsey Goodwin |
Assumes | Overweight | $9 |
| 2025-10-16 | StifelLaura Prendergast |
Reinstates | Buy | $8 |
| 2025-09-04 | GuggenheimBrad Canino |
Initiates coverage on | Buy | $8 |
| 2025-08-11 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $12 → $10 |
| 2025-07-01 | Raymond JamesSean McCutcheon |
Reinstates | Outperform | $11 |
| 2025-03-18 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $11 → $12 |
| 2025-03-07 | StifelBradley Canino |
Maintains | Buy | $16 → $15 |
| 2024-11-06 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $11 |
| 2024-10-09 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $11 |
| 2024-10-08 | WedbushRobert Driscoll |
Reiterates | Outperform | $16 |
| 2024-09-24 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $11 |
| 2024-09-23 | Piper SandlerJoseph Catanzaro |
Maintains | Overweight | $12 → $15 |
| 2024-09-18 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $11 |
| 2024-09-10 | WedbushRobert Driscoll |
Reiterates | Outperform | $16 |
| 2024-09-04 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $11 |
| 2024-08-07 | WedbushRobert Driscoll |
Reiterates | Outperform | $16 |
| 2024-07-31 | Raymond JamesLaura Prendergast |
Initiates coverage on | Outperform | $20 |
| 2024-07-03 | Piper SandlerJoseph Catanzaro |
Maintains | Overweight | $12 |
| 2024-06-07 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $11 |
| 2024-05-16 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $12 → $11 |
| 2024-04-08 | WedbushRobert Driscoll |
Maintains | Outperform | $10 → $16 |
| 2024-03-18 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $11 → $12 |
| 2024-03-13 | WedbushRobert Driscoll |
Reiterates | Outperform | $10 |
| 2023-11-22 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $11 |
| 2023-09-12 | WedbushRobert Driscoll |
Reiterates | Outperform | $10 |
| 2023-07-14 | Piper SandlerJoseph Catanzaro |
Initiates coverage on | Overweight | $11 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $2.02
- Market Cap
- $120.65 million
- 52-Week Range
- $1.60 – $4.94
- Average Volume
- 842K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.